General Information
Drug ID
DR00405
Drug Name
Gliquidone
Synonyms
1-Cyclohexyl-3-((p-(2-(3,4-dihydro-7-methoxy-4,4-dimethyl-1,3-dioxo-2(1H)-isoquinolyl)ethyl)phenyl)sulfonyl)urea; 1-cyclohexyl-3-(p-beta-(4,4-dimethyl-2-methoxy-1,3-(2H,4H)-isoquinolinedione-2-yl)phenethyl)sulfonylurea; 1-cyclohexyl-3-[4-[2-(7-methoxy-4,4-dimethyl-1,3-dioxoisoquinolin-2-yl)ethyl]phenyl]sulfonylurea; AR-DF 26; ARDF 26; ARDF 26 SE; Beglynor; Beglynora; Glikvidon; Gliquidona; Gliquidona [INN-Spanish]; Gliquidone (INN); Gliquidone [BAN:INN]; Gliquidonum; Gliquidonum [INN-Latin]; Glurenorm; Glurenorm (TN); Glycvidon; N-[(cyclohexylamino)carbonyl]-4-{2-[4,4-dimethyl-7-(methyloxy)-1,3-dioxo-3,4-dihydroisoquinolin-2(1H)-yl]ethyl}benzenesulfonamide
Drug Type
Small molecular drug
Therapeutic Class
Hypoglycemic Agents
Structure
3D MOL 2D MOL
Formula
C27H33N3O6S
Canonical SMILES
CC1(C2=C(C=C(C=C2)OC)C(=O)N(C1=O)CCC3=CC=C(C=C3)S(=O)(=O)NC(=O)NC4CCCCC4)C
InChI
InChI=1S/C27H33N3O6S/c1-27(2)23-14-11-20(36-3)17-22(23)24(31)30(25(27)32)16-15-18-9-12-21(13-10-18)37(34,35)29-26(33)28-19-7-5-4-6-8-19/h9-14,17,19H,4-8,15-16H2,1-3H3,(H2,28,29,33)
InChIKey
LLJFMFZYVVLQKT-UHFFFAOYSA-N
CAS Number
CAS 33342-05-1
Pharmaceutical Properties Molecular Weight 527.6 Topological Polar Surface Area 130
Heavy Atom Count 37 Rotatable Bond Count 7
Hydrogen Bond Donor Count 2 Hydrogen Bond Acceptor Count 6
XLogP
4.6
PubChem CID
91610
PubChem SID
10224909 ,103481945 ,103914607 ,104405238 ,105585086 ,11112731 ,11467019 ,11468139 ,11486708 ,121363658 ,124882576 ,124882577 ,125204729 ,125348208 ,126622557 ,126654118 ,126739661 ,128505786 ,131310850 ,134338200 ,135049036 ,137005778 ,14860897 ,44422540 ,46508425 ,47381693 ,47381694 ,47604985 ,47901629 ,48351264 ,48416055 ,49699236 ,49832468 ,49881412 ,50060569 ,50085433 ,50124024 ,50796154 ,56463591 ,57334969 ,7449309 ,7849488 ,7979418 ,81041002 ,81065941 ,81092899 ,85787540 ,87560715 ,92125987 ,92717029
ChEBI ID
ChEBI:93416
TTD Drug ID
D06HBQ

If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.